Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
J&L Railroad: The Board Meeting
Eades, Kenneth M.; Lehman, Jeannine; Green, RickCaso DARDEN-F-1605-EFinanzasThis short case could be handed out at the end of class discussion on “J&L Railroad” [UVA-F-1053] in preparation for the following class, or if students are more experienced with hedging and option pricing, the instructor may choose to cover both cases in a single class period. It is the companion case to “J&L Railroad" [UVA-F-1053], and presents more technical issues regarding the hedging problem by requiring students to understand option-pricin...Desde 8,20 €
-
Monsanto Company
Lipson, Marc L.; Green, RickCaso DARDEN-F-1597-EFinanzasMonsanto is facing an uncertain near-term financial outlook, and this case challenges students to generate an operating forecast (income statement and balance sheet operating accounts). The case naturally lends itself to sensitivity analysis related to sales growth assumptions. Suitable for MBA and undergraduate learners, it covers the basics of forecasting without introducing the complexities associated with financing. A teaching note is availab...Desde 8,20 €
-
Hartford Financial Services Group, Inc.
Sihler, William W.; Green, RickCaso DARDEN-F-1678-EFinanzasThe senior managers of the Hartford have been challenged by an activist investor (John Paulson) to alter the company's strategy as a way to enhance shareholder value - the company's market price not being revealed from its 2008 fall. Management must decide how to respond.Desde 8,20 €
-
Genzyme and Relational Investors: Science and Business Collide?
Eades, Kenneth M.; Matos, Pedro; Green, RickCaso DARDEN-F-1660-EFinanzasThe chairman and CEO of the Genzyme Corporation, one of the country’s top five biotechnology firms, has received a phone call requesting a meeting with the cofounder and principal of a large activist investment fund that now has a 2.6% stake in his company. Before meeting with him, the CEO is aware that he needs a strategy for dealing with this “activist” investor with a track record of forcing out CEOs.Desde 8,20 €
-
Research Affiliates
Evans, Richard B.; Green, RickCaso DARDEN-F-1662-EFinanzasTowers Watson (TW) has always conducted its own research into alternative approaches to market cap investing. A senior investment consultant with TW, impressed by a recent presentation by the CIO of Research Affiliates (RA) about an innovative investing concept called the “Fundamental Index methodology,” thinks it might be an important innovation in applying nonmarket cap approaches. But he has some concerns about the approach and whether or not ...Desde 8,20 €
-
Catalyst Health Solutions: A Script for Success?
Harris, Robert S.; Green, RickCaso DARDEN-F-1666-EFinanzasIn February 2011, David Blair, CEO of Catalyst Health Solutions, was considering another acquisition. Catalyst was already the fastest-growing pharmacy benefit management company in the United States, and Blair had his eye on a subsidiary of Walgreen Co., the second-largest retail drugstore chain in the country. Walgreen Co. was focusing its corporate strategy on the retail business and had just purchased 258 Duane Reade pharmacies in New York fo...Desde 8,20 €